StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)

Close on Nov 16, 2026Market cap $4.65BP/E –Yield –

Ionis Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Ionis Pharmaceuticals's cash was $2.05B at Jun 30, 2026. For fiscal 2025 it was $2.68B, up 16.5% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $2.68B in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.68B+16.5%
FY2024Dec 31, 2024$2.30B-1.4%
FY2023Dec 31, 2023$2.33B+17.3%
FY2022Dec 31, 2022$1.99B-6.1%
FY2021Dec 31, 2021$2.11B+11.8%
FY2020Dec 31, 2020$1.89B-24.3%
FY2019Dec 31, 2019$2.50B+19.9%
FY2018Dec 31, 2018$2.08B+103.8%
FY2017Dec 31, 2017$1.02B+53.7%
FY2016Dec 31, 2016$665.22M-14.6%
FY2015Dec 31, 2015$779.18M+6.9%
FY2014Dec 31, 2014$728.83M+11.0%
FY2013Dec 31, 2013$656.76M+75.4%
FY2012Dec 31, 2012$374.45M+9.0%
FY2011Dec 31, 2011$343.66M-27.2%
FY2010Dec 31, 2010$472.35M+348.8%
FY2009Dec 31, 2009$105.26M-53.0%
FY2008Dec 31, 2008$223.99M+61.6%
FY2007Dec 31, 2007$138.61M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.05B-10.3%
Q1 FY2026Mar 31, 2026$1.92B-10.5%
Q4 FY2025Dec 31, 2025$2.68B+16.5%
Q3 FY2025Sep 30, 2025$2.24B-9.8%
Q2 FY2025Jun 30, 2025$2.29B+10.2%
Q1 FY2025Mar 31, 2025$2.15B-2.8%
Q4 FY2024Dec 31, 2024$2.30B-1.4%
Q3 FY2024Sep 30, 2024$2.48B+11.1%
Q2 FY2024Jun 30, 2024$2.08B-12.9%
Q1 FY2024Mar 31, 2024$2.21B-6.0%
Q4 FY2023Dec 31, 2023$2.33B+17.3%
Q3 FY2023Sep 30, 2023$2.24B+12.8%
Q2 FY2023Jun 30, 2023$2.39B+18.0%
Q1 FY2023Mar 31, 2023$2.35B+14.3%
Q4 FY2022Dec 31, 2022$1.99B-6.1%
Q3 FY2022Sep 30, 2022$1.98B-0.3%
Q2 FY2022Jun 30, 2022$2.02B-1.8%
Q1 FY2022Mar 31, 2022$2.05B+12.8%
Q4 FY2021Dec 31, 2021$2.11B+11.8%
Q3 FY2021Sep 30, 2021$1.99B-14.7%
Q2 FY2021Jun 30, 2021$2.06B-12.3%
Q1 FY2021Mar 31, 2021$1.82B-23.7%
Q4 FY2020Dec 31, 2020$1.89B-24.3%
Q3 FY2020Sep 30, 2020$2.33B+4.9%
Q2 FY2020Jun 30, 2020$2.35B+3.8%
Q1 FY2020Mar 31, 2020$2.38B+5.8%
Q4 FY2019Dec 31, 2019$2.50B+19.9%
Q3 FY2019Sep 30, 2019$2.22B+13.4%
Q2 FY2019Jun 30, 2019$2.26B+14.2%
Q1 FY2019Mar 31, 2019$2.25B+117.7%
Q4 FY2018Dec 31, 2018$2.08B+103.8%
Q3 FY2018Sep 30, 2018$1.96B+93.8%
Q2 FY2018Jun 30, 2018$1.98B+131.4%
Q1 FY2018Mar 31, 2018$1.04B+20.3%
Q4 FY2017Dec 31, 2017$1.02B+53.7%
Q3 FY2017Sep 30, 2017$1.01B+47.0%
Q2 FY2017Jun 30, 2017$855.71M–
Q1 FY2017Mar 31, 2017$860.28M–
Q4 FY2016Dec 31, 2016$665.22M–
Q3 FY2016Sep 30, 2016$687.85M–

More Ionis Pharmaceuticals figures

See a number that looks wrong?